Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Anixa Biosciences Inc | Financial_Report.xls |
| 10-K - FORM 10-K - Anixa Biosciences Inc | d277634d10k.htm |
| EX-32.2 - STATEMENT OF CHIEF FINANCIAL OFFICER, PURSUANT TO SECTION 1350 - Anixa Biosciences Inc | d277634dex322.htm |
| EX-32.1 - STATEMENT OF CHIEF EXECUTIVE OFFICER, PURSUANT TO SECTION 1350 - Anixa Biosciences Inc | d277634dex321.htm |
| EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER, PURSUANT TO SECTION 302 - Anixa Biosciences Inc | d277634dex311.htm |
| EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER, PURSUANT TO SECTION 302 - Anixa Biosciences Inc | d277634dex312.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
CopyTele, Inc.:
We consent to the incorporation by reference in the registration statements (Nos. 333-105012, 333-120333, 333-132544, 333-146261, 333-156836, 333-168223 and 333-175392) on Form S-8 of CopyTele, Inc. of our report dated January 30, 2012, with respect to the consolidated balance sheets of CopyTele, Inc. and subsidiaries as of October 31, 2011 and 2010, and the related consolidated statements of operations, shareholders’ equity and cash flows for each of the years then ended, which report appears in the October 31, 2011 annual report on Form 10-K of CopyTele, Inc.
KPMG LLP
Melville, New York
January 30, 2012